Polymerase Chain Reaction PCR Sequencer

Polymerase Chain Reaction PCR Sequencer Market Outlook

The global Polymerase Chain Reaction (PCR) sequencer market is anticipated to reach approximately USD 10 billion by 2035, growing at a compound annual growth rate (CAGR) of around 8.5% during the forecast period. This growth is driven by the rising prevalence of infectious diseases, the increased focus on personalized medicine, and a growing demand for rapid and accurate diagnostic testing methods. Furthermore, advancements in PCR technology, such as the development of digital PCR and real-time PCR, are significantly contributing to market expansion. The urgent need for efficient genetic analysis in areas like drug development, cancer research, and environmental testing is also propelling the demand for PCR sequencers. As healthcare systems across the globe continue to evolve, the accessibility and reliability of PCR technology are expected to play a crucial role in shaping the future of molecular diagnostics.

Growth Factor of the Market

Several factors are driving the growth of the PCR sequencer market. Firstly, the increasing incidence of infectious diseases and genetic disorders is prompting healthcare professionals to seek more reliable diagnostic tools. PCR technology allows for the rapid detection of pathogens, enabling timely treatment and management of diseases. Secondly, advancements in molecular biology and genomics have led to an uptick in research activities, especially in academic and research institutions, where PCR sequencing is a fundamental technique for analysis. Additionally, the rise in funding for biotechnology and pharmaceutical research is promoting innovation and the introduction of more sophisticated PCR sequencers. The COVID-19 pandemic has further accentuated the importance of PCR testing, as it became a cornerstone for the diagnosis and management of the virus. Lastly, the growing trend of point-of-care testing is creating new opportunities for portable and user-friendly PCR devices, making them accessible in various healthcare settings.

Key Highlights of the Market

• The PCR sequencer market is expected to grow at a CAGR of 8.5% from 2025 to 2035.
• Increasing demand for rapid diagnostic testing is driving advancements in PCR technology.
• Digital PCR and real-time PCR are gaining popularity due to their high sensitivity and specificity.
• The COVID-19 pandemic has significantly boosted the awareness and adoption of PCR testing.
• Portable PCR sequencers are emerging as a prominent trend in point-of-care diagnostics.

By Product Type

Standard PCR Sequencers:

Standard PCR sequencers are among the most widely used devices in laboratories, primarily due to their reliability and cost-effectiveness. These sequencers function by amplifying DNA samples, allowing researchers to analyze genetic material for various applications, including research and diagnostic purposes. The demand for standard PCR sequencers is bolstered by their ease of use, which makes them suitable for academic and clinical settings. Moreover, their ability to handle multiple samples simultaneously enhances throughput, thus making them an essential tool for many laboratories. As the market continues to evolve, manufacturers are focusing on improving the efficiency and accuracy of these devices, further solidifying their role within the PCR landscape.

Real-time PCR Sequencers:

Real-time PCR sequencers, also known as quantitative PCR (qPCR) sequencers, offer enhanced sensitivity and specificity compared to traditional PCR methods. The ability to monitor the amplification of DNA in real-time provides researchers with immediate results, making this technology invaluable for applications in clinical diagnostics and research. The growing demand for precise quantitative analysis in various fields, including oncology and infectious disease detection, is driving the adoption of real-time PCR sequencers. Additionally, advancements in fluorescent dye chemistry and detection technologies have further improved the performance of these devices, leading to a surge in their usage across laboratories globally. As healthcare professionals seek more accurate diagnostic tools, real-time PCR sequencers are expected to witness significant market growth.

Digital PCR Sequencers:

Digital PCR (dPCR) sequencers represent the next frontier in PCR technology by providing absolute quantification of DNA without the need for standard curves. This technology is particularly beneficial for applications that require high precision, such as rare mutation detection and copy number variation analysis. Digital PCR offers enhanced sensitivity and robustness, making it suitable for complex sample matrices, including those found in oncology and infectious disease research. The ongoing development and commercialization of dPCR technologies are expected to foster increased adoption in both research and clinical settings. As researchers continue to demand greater accuracy and reliability in molecular diagnostics, the digital PCR segment is anticipated to experience substantial growth in the coming years.

Traditional PCR Sequencers:

Traditional PCR sequencers have been instrumental in developing molecular biology, serving as the foundation for many genetic studies and applications. While newer technologies have emerged, traditional PCR devices remain relevant due to their established protocols, familiarity among users, and lower costs. These sequencers are commonly used in educational institutions and laboratories that require basic DNA amplification capabilities. However, with the increasing emphasis on efficiency and accuracy in diagnostics, the traditional PCR segment is expected to face challenges in maintaining its market share against more sophisticated alternatives. Manufacturers are working on integrating modern features into traditional PCR devices to enhance their appeal in an evolving market landscape.

Portable PCR Sequencers:

Portable PCR sequencers have gained traction as critical diagnostic tools in point-of-care testing, where rapid results are essential. These devices enable testing in various settings, including remote locations, rural areas, and emergency response situations. The convenience and accessibility of portable PCR sequencers are driving their adoption among healthcare professionals. Furthermore, the COVID-19 pandemic highlighted the need for rapid testing solutions, leading to increased interest and investment in portable PCR technologies. As advancements continue in miniaturization and battery life, portable PCR sequencers are likely to become more prevalent in diverse applications, from clinical diagnostics to environmental monitoring.

By Application

Clinical Diagnostics:

Clinical diagnostics is one of the primary applications driving the PCR sequencer market. The ability to rapidly and accurately detect pathogens, genetic disorders, and mutations plays a crucial role in patient management and treatment decisions. PCR technology has become a cornerstone in diagnostics, particularly in infectious disease testing, where timely results can significantly impact patient outcomes. The ongoing development of new biomarkers and assays is expected to further enhance the utility of PCR in clinical settings, making it an indispensable tool for healthcare providers. As the demand for personalized medicine increases, the application of PCR sequencers in clinical diagnostics is predicted to grow steadily, catering to the evolving needs of the healthcare industry.

Research:

The research application of PCR sequencers is integral to advancing our understanding of molecular biology, genomics, and biotechnology. Researchers utilize PCR technology to amplify DNA for various studies, including genetic mapping, gene expression analysis, and phylogenetic studies. The increasing focus on research in fields such as cancer biology, microbiology, and environmental science is propelling the demand for PCR sequencers in laboratories worldwide. As funding for research initiatives continues to rise, so will the adoption of PCR technology, with researchers seeking more advanced, efficient, and reliable tools for their studies. The growth of the research sector, especially in academic institutions and private laboratories, is expected to significantly contribute to the overall market expansion of PCR sequencers.

Forensics:

Forensic applications of PCR sequencers are critical in criminal investigations, where DNA profiling plays a pivotal role in evidence analysis. PCR technology allows forensic scientists to amplify minute quantities of DNA found at crime scenes, enabling the identification of individuals based on genetic material. The increasing use of PCR in forensics has transformed the landscape of criminal justice by providing accurate and reliable evidence in court cases. As technology evolves, the integration of next-generation sequencing (NGS) and advanced PCR techniques is expected to enhance the capabilities of forensic investigations. The growing emphasis on improving forensic methodologies and the increasing number of criminal cases are likely to drive the demand for PCR sequencers in the forensics sector.

Others:

Other applications of PCR sequencers include environmental monitoring, agricultural biotechnology, and veterinary diagnostics. In environmental science, PCR is employed to detect specific pathogens in water and soil samples, contributing to public health and environmental safety. In agriculture, PCR is used for the identification of genetically modified organisms (GMOs) and the detection of plant pathogens, supporting food security and crop health. Veterinary diagnostics also benefit from PCR technology, facilitating the identification of diseases in animals and ensuring livestock health. As awareness of the importance of genetic analysis in various industries grows, the diverse applications of PCR sequencers are expected to expand, further propelling market growth.

By Distribution Channel

Hospitals and Clinics:

The distribution of PCR sequencers through hospitals and clinics constitutes a significant segment of the market, driven by the increasing need for rapid diagnostic testing in healthcare settings. Hospitals and clinics utilize PCR technology to diagnose infectious diseases, evaluate genetic disorders, and conduct prenatal screening. The integration of PCR sequencers into routine clinical practice enhances the ability of healthcare providers to deliver timely and accurate diagnostic services. Moreover, the ongoing investment in healthcare infrastructure and the growing emphasis on point-of-care testing are expected to fuel the demand for PCR sequencers in hospitals and clinics, ensuring they have access to the latest technology for patient care.

Diagnostic Centers:

Diagnostic centers play a pivotal role in the distribution of PCR sequencers, serving as dedicated facilities that provide specialized testing services to healthcare providers and patients. These centers are often equipped with advanced laboratory technologies, making them ideal environments for the implementation of PCR diagnostics. The growing demand for diagnostic services, particularly in the context of infectious diseases and genetic testing, is driving the adoption of PCR sequencers within these facilities. As the focus on early detection and prevention of diseases continues to rise, diagnostic centers are expected to play an increasingly important role in the PCR sequencer market, contributing to the overall growth of the industry.

Research Institutes:

Research institutes are crucial stakeholders in the PCR sequencer market, as they utilize these devices extensively for a wide array of scientific studies. These institutes often lead the charge in developing new PCR methodologies and applications, contributing to advancements in molecular biology and genomics. The increasing investment in research and development initiatives, particularly in fields such as cancer research, genetics, and infectious diseases, is driving the demand for PCR sequencers in research settings. As scientific exploration continues to progress, research institutes are expected to remain significant consumers of PCR technology, fostering innovation and discovery in the life sciences.

Others:

Other distribution channels for PCR sequencers include online platforms and direct sales to end-users. The rise of e-commerce has facilitated the acquisition of laboratory equipment, including PCR sequencers, making it easier for customers to access these technologies. Additionally, manufacturers often engage in direct sales to laboratories and research facilities, ensuring they have the necessary support and training to utilize PCR technology effectively. The diversification of distribution channels is expected to enhance the accessibility of PCR sequencers, catering to the growing demand from various sectors, including healthcare, research, and diagnostics.

By Technology Type

qPCR:

Quantitative PCR, or qPCR, is a widely adopted technology within the PCR sequencer market, known for its ability to quantify nucleic acids in real-time. This method is particularly favored in clinical diagnostics and research due to its high sensitivity and specificity. By monitoring the amplification of DNA in real-time, researchers can obtain quantitative data that is critical for various applications, including gene expression studies, pathogen detection, and genetic analysis. The continuous advancements in qPCR technology, such as improved reagents and detection systems, are expected to enhance its performance and further expand its application in the market. As the focus on accurate and timely diagnostics continues to grow, qPCR is poised to remain a dominant technology type in the PCR sequencer landscape.

dPCR:

Digital PCR (dPCR) is emerging as a transformative technology within the PCR sequencer market, offering unparalleled precision and sensitivity for quantifying nucleic acids. Unlike traditional PCR methods, dPCR provides absolute quantification without the need for standard curves, making it a valuable tool in applications requiring high accuracy, such as rare mutation detection and copy number variation analysis. The growing recognition of dPCR's advantages over conventional methods is driving its adoption in research and clinical laboratories. As the technology continues to evolve, with further enhancements in sensitivity and multiplexing capabilities, dPCR is expected to capture a larger share of the PCR sequencer market.

Traditional PCR:

Traditional PCR remains an essential technology in the PCR sequencer market, serving as the foundation for many molecular biology applications. This conventional method is widely used for amplifying DNA samples, and while newer technologies have emerged, it continues to be favored for its simplicity and cost-effectiveness. Traditional PCR is particularly useful in educational settings and laboratories that require basic DNA amplification capabilities. However, as the demand for efficiency and precision increases, traditional PCR may face challenges in competing with more sophisticated alternatives. Manufacturers are actively working to enhance traditional PCR systems by integrating modern features to ensure they remain relevant in a rapidly evolving market.

By Region

North America leads the global PCR sequencer market with a significant share, driven primarily by the presence of advanced healthcare infrastructure, strong investment in research and development, and a high prevalence of infectious diseases. The United States is at the forefront of this growth, where a substantial demand for rapid diagnostic testing has emerged, particularly in light of the COVID-19 pandemic. The North American market is expected to grow at a CAGR of approximately 8.2% from 2025 to 2035, reflecting the ongoing commitment to innovation and integration of cutting-edge PCR technologies in clinical and research settings. The high adoption rate of point-of-care testing solutions is further propelling the market in this region.

Europe is also experiencing robust growth in the PCR sequencer market, primarily driven by the increasing focus on personalized medicine and advancements in molecular diagnostics. Countries such as Germany, France, and the United Kingdom are key contributors to this market expansion, supported by strong healthcare systems and a growing number of research initiatives. The European market is projected to grow at a CAGR of approximately 7.5% during the forecast period, as healthcare providers continue to leverage PCR technology for a variety of applications, including clinical diagnostics and research. The increasing collaboration between public and private sectors to promote innovation in molecular diagnostics is expected to further enhance market growth in this region.

Opportunities

The PCR sequencer market presents a myriad of opportunities driven by advancements in technology and an increasing emphasis on molecular diagnostics. One notable opportunity lies in the development of next-generation sequencing (NGS) technology, which is poised to complement traditional PCR methods by offering deeper insights into genetic material. As NGS becomes more accessible and affordable, there is potential for integration with PCR applications, enhancing the capabilities of laboratories and expanding their research horizons. Additionally, the growing trend of personalized medicine presents an opportunity for PCR sequencers, as healthcare providers seek reliable diagnostic tools to tailor treatments to individual patient profiles. Furthermore, increasing awareness of the importance of early disease detection and prevention is driving demand for point-of-care testing solutions, particularly portable and user-friendly PCR devices, which can be deployed in remote locations and emergency situations.

Moreover, the growing interest in environmental applications of PCR technology presents significant opportunities for market growth. As concerns surrounding food safety, water quality, and biodiversity gain prominence, PCR sequencers can provide essential tools for detecting pathogens and contaminants in environmental samples. The increasing regulatory scrutiny on food and water safety is likely to boost demand for PCR technology in these sectors. Additionally, the rise of telemedicine and remote healthcare solutions has created new avenues for portable PCR testing, allowing patients to receive timely diagnoses without the need for clinical visits. As these trends continue to evolve, the PCR sequencer market is well-positioned to capitalize on emerging opportunities across various sectors.

Threats

While the PCR sequencer market is poised for growth, it also faces several threats that could hinder its progress. One of the primary concerns is the rapid pace of technological advancements, which can make existing products obsolete. As new PCR technologies and methodologies emerge, manufacturers must continuously innovate to remain competitive, leading to increased research and development costs. Moreover, the highly competitive nature of the market means that companies may engage in price wars to capture market share, which can negatively impact profit margins for manufacturers. Additionally, fluctuating regulatory environments and stringent quality control measures in different countries may pose challenges for companies seeking to enter new markets or deploy their technologies globally. The need for compliance with varying regulations can complicate market entry strategies and increase operational costs.

Another significant threat to the PCR sequencer market is the potential for supply chain disruptions. The COVID-19 pandemic highlighted vulnerabilities in global supply chains, and any future disruptions—whether due to pandemics, natural disasters, or geopolitical tensions—could impact the availability of key components and raw materials required for manufacturing PCR sequencers. Such disruptions could lead to delays in product development and delivery, adversely affecting market growth. Additionally, the increasing prevalence of alternative molecular diagnostic technologies, such as CRISPR-based methods, may pose a long-term threat to traditional PCR technologies if they gain broader acceptance and prove to be more efficient or cost-effective.

Competitor Outlook

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• QIAGEN N.V.
• Roche Diagnostics
• Agilent Technologies, Inc.
• Abbott Laboratories
• PerkinElmer, Inc.
• Illumina, Inc.
• Takara Bio Inc.
• Merck KGaA
• Gene Bioalign
• Promega Corporation
• Cegelec
• Biomérieux SA
• F. Hoffmann-La Roche AG

The competitive landscape of the PCR sequencer market is characterized by the presence of numerous global and regional players, each vying for market share through innovation, product development, and strategic collaborations. Major companies such as Thermo Fisher Scientific and Bio-Rad Laboratories dominate the market due to their extensive product portfolios and strong brand recognition. These companies invest significantly in research and development to introduce advanced PCR technologies, enhancing performance and addressing the evolving needs of end-users. The growing focus on personalized medicine and molecular diagnostics has prompted these companies to explore new applications and expand their offerings in the PCR space.

Additionally, companies like QIAGEN and Roche Diagnostics are focusing on the integration of PCR technologies with next-generation sequencing (NGS) platforms, promoting a more comprehensive approach to genetic analysis. This trend is expected to attract research institutions and healthcare providers seeking to leverage the advantages of both PCR and NGS technologies in their diagnostic workflows. Furthermore, partnerships between manufacturers and academic institutions are fostering innovation and driving the development of novel PCR applications, positioning these companies at the forefront of the market.

Emerging companies are also making their mark in the PCR sequencer market, particularly those specializing in portable and user-friendly technologies. Companies such as Agilent Technologies and Illumina are exploring opportunities in point-of-care testing solutions, recognizing the growing demand for rapid diagnostic tools in various healthcare settings. By focusing on developing compact and efficient PCR devices, these companies aim to capture the attention of healthcare professionals and researchers looking for solutions that offer accessibility without compromising on performance. As competition intensifies, these companies will need to differentiate themselves through innovative features and robust customer support.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cegelec
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck KGaA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 QIAGEN N.V.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Gene Bioalign
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Illumina, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Takara Bio Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 PerkinElmer, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Roche Diagnostics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Abbott Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Promega Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Biomérieux SA
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 F. Hoffmann-La Roche AG
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Agilent Technologies, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Bio-Rad Laboratories, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Thermo Fisher Scientific Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Polymerase Chain Reaction PCR Sequencer Market, By Application
    • 6.1.1 Clinical Diagnostics
    • 6.1.2 Research
    • 6.1.3 Forensics
    • 6.1.4 Others
  • 6.2 Polymerase Chain Reaction PCR Sequencer Market, By Product Type
    • 6.2.1 Standard PCR Sequencers
    • 6.2.2 Real-time PCR Sequencers
    • 6.2.3 Digital PCR Sequencers
    • 6.2.4 Traditional PCR Sequencers
    • 6.2.5 Portable PCR Sequencers
  • 6.3 Polymerase Chain Reaction PCR Sequencer Market, By Technology Type
    • 6.3.1 qPCR
    • 6.3.2 dPCR
    • 6.3.3 Traditional PCR
  • 6.4 Polymerase Chain Reaction PCR Sequencer Market, By Distribution Channel
    • 6.4.1 Hospitals and Clinics
    • 6.4.2 Diagnostic Centers
    • 6.4.3 Research Institutes
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Polymerase Chain Reaction PCR Sequencer Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Polymerase Chain Reaction PCR Sequencer market is categorized based on

By Product Type

• Standard PCR Sequencers
• Real-time PCR Sequencers
• Digital PCR Sequencers
• Traditional PCR Sequencers
• Portable PCR Sequencers

By Application

• Clinical Diagnostics
• Research
• Forensics
• Others

By Distribution Channel

• Hospitals and Clinics
• Diagnostic Centers
• Research Institutes
• Others

By Technology Type

• qPCR
• dPCR
• Traditional PCR

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• QIAGEN N.V.
• Roche Diagnostics
• Agilent Technologies, Inc.
• Abbott Laboratories
• PerkinElmer, Inc.
• Illumina, Inc.
• Takara Bio Inc.
• Merck KGaA
• Gene Bioalign
• Promega Corporation
• Cegelec
• Biomérieux SA
• F. Hoffmann-La Roche AG